Augmedix, Inc. – NASDAQ:AUGX
Augmedix stock price today
$2.35
+1.43
+156.38%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 11 hours
Augmedix stock price monthly change
+9.17%
month
Augmedix stock price quarterly change
-78.06%
quarter
Augmedix stock price yearly change
-79.85%
year
Augmedix key metrics
Market Cap | 115.90M |
Enterprise value | 57.44M |
P/E | -2.66 |
EV/Sales | 1.99 |
EV/EBITDA | -2.56 |
Price/Sales | 2.31 |
Price/Book | 10.32 |
PEG ratio | N/A |
EPS | -0.42 |
Revenue | 48.69M |
EBITDA | -19.34M |
Income | -20.43M |
Revenue Q/Q | 39.91% |
Revenue Y/Y | 45.03% |
Profit margin | -84.58% |
Oper. margin | -75.74% |
Gross margin | 44.65% |
EBIT margin | -75.74% |
EBITDA margin | -39.72% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAugmedix stock price history
Augmedix stock forecast
Augmedix financial statements
| Jun 2023 | 10.78M | -5.03M | -46.69% |
|---|---|---|---|
| Sep 2023 | 11.76M | -4.40M | -37.45% |
| Dec 2023 | 12.68M | -4.49M | -35.42% |
| Mar 2024 | 13.47M | -6.49M | -48.24% |
| Mar 2024 | 13.47M | -6.49M | -48.24% |
|---|---|---|---|
| Sep 2025 | 21.55M | -3.67M | -17.06% |
| Oct 2025 | 17.48M | -6.10M | -34.89% |
| Dec 2025 | 18.71M | -5.04M | -26.93% |
Analysts Price target
Financials & Ratios estimates
| 2023-11-06 | -0.12 | -0.1 |
|---|---|---|
| 2024-03-18 | -0.1 | -0.09 |
| 2024-05-13 | -0.12 | -0.12 |
| Jun 2023 | 43848000 | 39.85M | 90.9% |
|---|---|---|---|
| Sep 2023 | 40833000 | 40.09M | 98.2% |
| Dec 2023 | 66712000 | 43.39M | 65.04% |
| Mar 2024 | 59556000 | 41.77M | 70.15% |
| Jun 2023 | -5.95M | -1.30M | 11.88M |
|---|---|---|---|
| Sep 2023 | -2.29M | -437K | 20K |
| Dec 2023 | -973K | -1.19M | 26.38M |
| Mar 2024 | -8.23M | -542K | 59K |
Augmedix alternative data
| Aug 2023 | 1,040 |
|---|---|
| Sep 2023 | 1,040 |
| Oct 2023 | 1,040 |
| Nov 2023 | 1,040 |
| Dec 2023 | 1,040 |
| Jan 2024 | 1,040 |
| Feb 2024 | 1,040 |
| Mar 2024 | 1,040 |
| Apr 2024 | 1,040 |
| May 2024 | 1,430 |
| Jun 2024 | 1,430 |
| Jul 2024 | 1,430 |
Augmedix other data
24.51%
-34.34%
of AUGX is owned by hedge funds
9.17M
-12.85M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2023 | 26529 | 0 |
| Nov 2023 | 1510000 | 0 |
| Mar 2024 | 0 | 31994 |
| Apr 2024 | 0 | 409400 |
| May 2024 | 0 | 13157 |
| Quarter | Transcript |
|---|---|
| Q1 2024 13 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 18 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 6 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Emmanuel Krakaris (1959) Pres, Chief Executive Officer, Sec. & Director | $506,730 |
Mr. Jonathan Hawkins (1970) Chief Revenue Officer | $417,710 |
Ms. Sandra Breber (1958) Chief Operating Officer | $341,710 |
Buy Augmedix After $25 Million Equity Funding Round
Augmedix: Using Generative AI To Document Medical Records
Augmedix: Using AI To Make Healthcare More Efficient
Augmedix Prepares For Continued Growth With HCA Collaboration
Augmedix: Buy This Under-The-Radar AI Stock
Augmedix, Inc. 2022 Q1 - Results - Earnings Call Presentation
Augmedix (AUGX) Investor Presentation - Slideshow
-
What's the price of Augmedix stock today?
One share of Augmedix stock can currently be purchased for approximately $2.35.
-
When is Augmedix's next earnings date?
Unfortunately, Augmedix's (AUGX) next earnings date is currently unknown.
-
Does Augmedix pay dividends?
No, Augmedix does not pay dividends.
-
How much money does Augmedix make?
Augmedix has a market capitalization of 115.90M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 45.01% to 44.86M US dollars. Augmedix made a loss 19.17M US dollars in net income (profit) last year or -$0.12 on an earnings per share basis.
-
What is Augmedix's stock symbol?
Augmedix, Inc. is traded on the NASDAQ under the ticker symbol "AUGX".
-
What is Augmedix's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Augmedix?
Shares of Augmedix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Augmedix's key executives?
Augmedix's management team includes the following people:
- Mr. Emmanuel Krakaris Pres, Chief Executive Officer, Sec. & Director(age: 66, pay: $506,730)
- Mr. Jonathan Hawkins Chief Revenue Officer(age: 55, pay: $417,710)
- Ms. Sandra Breber Chief Operating Officer(age: 67, pay: $341,710)
-
How many employees does Augmedix have?
As Jul 2024, Augmedix employs 1,430 workers, which is 38% more then previous quarter.
-
When Augmedix went public?
Augmedix, Inc. is publicly traded company for more then 4 years since IPO on 31 Mar 2021.
-
What is Augmedix's official website?
The official website for Augmedix is augmedix.com.
-
Where are Augmedix's headquarters?
Augmedix is headquartered at 111 Sutter Street, San Francisco, CA.
-
How can i contact Augmedix?
Augmedix's mailing address is 111 Sutter Street, San Francisco, CA and company can be reached via phone at +888 6694885.
Augmedix company profile:
Augmedix, Inc.
augmedix.comExchange:
NASDAQ
Full time employees:
1,430
Industry:
Medical - Healthcare Information Services
Sector:
Healthcare
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.
111 Sutter Street
San Francisco, CA 94104
San Francisco, CA 94104
CIK: 0001769804
ISIN: US05105P1075
CUSIP: 05105P107
